Feasibility and robustness of amplification refractory mutation system (ARMS)-based KRAS testing using clinically available formalin-fixed, paraffin-embedded samples of colorectal cancers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples